Franklin Resources
LAB icon

Franklin Resources’s Standard BioTools LAB Stock Holding History

Franklin Resources’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,988,962
Closed -$15.9M – 1491
2016
Q3 		$15.9M Sell
1,988,962
-4,405
-0.2% -$40.5K 0.01% 865
2016
Q2 		$18M Sell
1,993,367
-4,317
-0.2% -$40.6K 0.01% 835
2016
Q1 		$16.1M Sell
1,997,684
-85,867
-4% -$619K 0.01% 856
2015
Q4 		$22.5M Sell
2,083,551
-756,653
-27% -$7.43M 0.01% 805
2015
Q3 		$23M Buy
2,840,204
+187,748
+7% +$2.96M 0.01% 804
2015
Q2 		$64.2M Buy
2,652,456
+487,633
+23% +$15.4M 0.03% 522
2015
Q1 		$91.1M Buy
2,164,823
+158,556
+8% +$6.27M 0.04% 421
2014
Q4 		$67.7M Buy
2,006,267
+112,755
+6% +$3.19M 0.03% 502
2014
Q3 		$46.4M Buy
1,893,512
+544,577
+40% +$15.3M 0.02% 604
2014
Q2 		$39.7M Buy
1,348,935
+268,190
+25% +$8.59M 0.02% 682
2014
Q1 		$47.6M Buy
+1,080,745
New +$47.5M 0.02% 595

Other funds holding LAB

LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Franklin Resources's LAB Position: Q4 2016 in Review

Franklin Resources sold out of Standard BioTools (LAB) in Q4 2016, closing a stake of 1,988,962 shares — an estimated $15.9M sold.

Franklin Resources first reported a position in LAB in Q1 2014 and held it in 11 quarters. The position peaked at $91.1M in Q1 2015. 83 funds tracked by Wall St. Rank hold LAB as of Q4 2016.

  • Franklin Resources reported no remaining Standard BioTools position as of Q4 2016 after selling out during the quarter.
  • Franklin Resources sold 1,988,962 Standard BioTools shares in Q4 2016, an estimated $15.9M.
  • Franklin Resources first reported a position in Standard BioTools in Q1 2014 and held it in 11 quarters.
  • Franklin Resources's Standard BioTools position peaked at $91.1M in Q1 2015.
  • 83 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2016.

Based on Franklin Resources's 13F filing for Q4 2016, filed 14 Feb 2017.